—AJMC: UPL’s Present a Risk for Patients, Pharmacies and Providers. View the article here.
— Personalized Medicine Coalition Conference November 18-19. Register to attend here.
— Bipartisan Resolution Marking the 27th Anniversary of the Landmark Supreme Court Decision, Olmstead v. L.C. See details below.
— Beyond A Seat At The Table: Meaningful Patient Representation On Pharmacy And Therapeutics Committees. View the article here. View PIPC’s 2024 comment here.
— CMS Finalizes GLOBE Model, PIPC Opposes Importing QALYS. View the full statement here. Share concerns on X here and on LinkedIn here.
— USPSTF Changes Imply a Shift Toward Consideration of Cost Effectiveness. View the Inside Health Policy article here ($). View the AcademyHealth statement here.
— Legacy HTA: Deconstructing the Impossible QALY. View the Class Notes here.
— PCORI Seeking Input on Research Priorities. Click here to submit your ideas by Nov. 2.
— Join IVI for 2026 Whole Health Policy Summit in November. Learn more here. Register to attend in person here. Register to attend the livestream here.
— ICHOM Advances the Spinal Muscular Atrophy Patient Validation Survey, Plus Annual Conference December 7-9. Complete the Patient Validation Survey here and register for the conference here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.